INFLAMMX THERAPEUTICS, INC.

Profile

Company Names

INFLAMMX THERAPEUTICS, INC.

Addresses

275 BAYSHORE BLVD, UNIT 1607, TAMPA, FL 33606

Phone Numbers

858-480-2404

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$15,384,485.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-05-06 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2021-11-12 
$8,355,060.00 
$8,355,060.00 
$0.00 
Equity 
1
2020-12-30 
$7,029,425.00 
$7,029,425.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
BLAIR 
DIRECTOR
CELL BIOSCIENCES INC   |  HELIXIS INC   |  ASTUTE MEDICAL, INC.   |  FIVE PRIME THERAPEUTICS INC   |  CODA THERAPEUTICS INC   |  NEUROPACE INC   |  APPLIED PROTEOMICS, INC.   |  WIRELESS DIAGNOSTIC SYSTEMS, INC.   |  OCUNEXUS THERAPEUTICS, INC.   |  INFLAMMX THERAPEUTICS, INC.   |  CARROT LABS INC
DAVID 
 
BOYER 
DIRECTOR
INFLAMMX THERAPEUTICS, INC.
BRIAN 
 
LEVY 
EXECUTIVE OFFICER, DIRECTOR
OCULAR THERAPEUTIX, INC   |  AERIE PHARMACEUTICALS INC   |  INSITE VISION INC   |  VISION PATH, INC.   |  SILK TECHNOLOGIES, LTD.   |  OCUNEXUS THERAPEUTICS, INC.   |  INFLAMMX THERAPEUTICS, INC.   |  ZILKS PLUS RESOURCES LLC   |  PUP ABOVE, INC.   |  CONCIERGE PEDIATRICS HOLDINGS, LLC
DAVID 
 
POOL 
EXECUTIVE OFFICER
HOMEPIPE NETWORKS INC   |  HOMEPIPE NETWORKS INC   |  CODA THERAPEUTICS INC   |  ORTHOPAEDIC SYNERGY INC   |  OMNI ORTHOPAEDICS INC   |  SWITCH, INC.   |  STRIVVE, INC.   |  OCUNEXUS THERAPEUTICS, INC.   |  INFLAMMX THERAPEUTICS, INC.   |  AERLINK LTD.
PHIL 
 
ROSENFELD 
DIRECTOR
INFLAMMX THERAPEUTICS, INC.
RICHARD 
 
RUBINO 
DIRECTOR
AERIE PHARMACEUTICALS INC   |  BEST AGENT TODAY, INC.   |  INFLAMMX THERAPEUTICS, INC.   |  FIGUR8, INC.
RAJIV 
 
SHUKLA 
DIRECTOR
INFLAMMX THERAPEUTICS, INC.   |  CARMELL CORP
JASON 
 
WERNER 
DIRECTOR
EYEVANCE HOLDINGS LLC   |  INFLAMMX THERAPEUTICS, INC.   |  KERA THERAPEUTICS, INC.   |  SIGHTSTREAM BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-06 
2021-11-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-12 
2021-01-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#